These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6260604)

  • 21. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol.
    Rogozea R; Florea-Ciocoiu V; Bălăiţă C; Luca N
    Neurol Psychiatr (Bucur); 1982; 20(2):89-100. PubMed ID: 7123121
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute polyneuropathy caused by diphenylhydantoin intoxication (author's transl)].
    Meienberg O; Bajc O
    Dtsch Med Wochenschr; 1975 Jul; 100(29):1532-4, 1539. PubMed ID: 168051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review.
    So EL; Penry JK
    Epilepsia; 1981 Aug; 22(4):467-73. PubMed ID: 6266823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diphenylhydantoin-induced gingival hyperplasia: its response to changes in drug dosage.
    Little TM; Girgis SS; Masotti RE
    Dev Med Child Neurol; 1975 Aug; 17(4):421-4. PubMed ID: 1158048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diphenylhydantoin poisoning in monotherapy and in combination with other antiepileptic drugs].
    Schelp AO; Weisner B
    Arq Neuropsiquiatr; 1985 Jun; 43(2):176-80. PubMed ID: 4062602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenytoin neuropathy: structural changes in the sural nerve.
    Ramirez JA; Mendell JR; Warmolts JR; Griggs RC
    Ann Neurol; 1986 Feb; 19(2):162-7. PubMed ID: 3008637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presenile cataracts in hydantoin-treated epileptic patients.
    Savir H; Bar S; Feller N
    Metab Pediatr Syst Ophthalmol; 1983; 7(3):169-71. PubMed ID: 6656625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacking the 'protective label' of diabetes: Phenytoin-induced distal symmetrical peripheral neuropathy. A clinical case report.
    Mahon AM
    J Tissue Viability; 2016 Nov; 25(4):225-228. PubMed ID: 27372177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative vibration perception thresholds in patients under prolonged antiepileptic treatment.
    Halonen P; Lang HA; Nyrke T
    Acta Neurol Scand; 1985 Sep; 72(3):307-11. PubMed ID: 2998143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of diabetic neuropathy with diphenylhydantoin.
    Ellenberg M
    N Y State J Med; 1968 Oct; 68(20):2653-5. PubMed ID: 4300475
    [No Abstract]   [Full Text] [Related]  

  • 31. Late peripheral neuropathy due to an acute voluntary intoxication by organophosphorus compounds.
    Curtes JP; Develay P; Hubert JP
    Clin Toxicol; 1981 Dec; 18(12):1453-62. PubMed ID: 6277553
    [No Abstract]   [Full Text] [Related]  

  • 32. Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin.
    Herha J; Obe G
    Hum Genet; 1976 Dec; 34(3):255-63. PubMed ID: 1002148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebellar atrophy following diphenylhydantoin intoxication.
    Baier WK; Beck U; Doose H; Klinge H; Hirsch W
    Neuropediatrics; 1984 May; 15(2):76-81. PubMed ID: 6738820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deafness and peripheral neuropathy following carbon monoxide intoxication--report of a case.
    Goto I; Miyoshi T; Ooya Y
    Folia Psychiatr Neurol Jpn; 1972 Jan; 26(1):35-8. PubMed ID: 4340697
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H; Mols-Thürkow I
    Eur J Clin Pharmacol; 1975; 8(1):75-8. PubMed ID: 1233204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyneuropathy in lithium intoxication.
    Vanhooren G; Dehaene I; Van Zandycke M; Piessens F; Vandenbergh V; Van Hees J; Lammens M; Carton H
    Muscle Nerve; 1990 Mar; 13(3):204-8. PubMed ID: 2157151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diphenylhydantoin and primary hypothyroidism].
    Gilsanz Peral A; Costa Talens P; Gómez Balaguer M
    Rev Clin Esp; 1986 Nov; 179(8):433-5. PubMed ID: 3562962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.